Respiratory insufficiency as a presenting symptom of congenital myasthenic syndromes

Fleur van den Udenhout1, Peter Merkus2, Sandra Verhaagen-van den Akker3

  • 1Department of Paediatric Neurology, Amalia Children's Hospital, Radboud University Medical Centre, Nijmegen, Netherlands.

Insights

Congenital myasthenic syndromes (CMS) can cause respiratory insufficiency in children. Early diagnosis and treatment with pyridostigmine can improve outcomes for affected infants and children.

Area of Science:

  • Pediatric Neurology
  • Rare Genetic Disorders
  • Respiratory Medicine

Background:

  • Congenital myasthenic syndromes (CMS) are rare genetic disorders affecting neuromuscular transmission.
  • Respiratory insufficiency is an underrecognized presenting symptom of CMS in pediatric patients.

Purpose of the Study:

  • To increase pediatrician awareness of CMS as a cause of respiratory insufficiency in children.
  • To highlight the importance of early diagnosis and treatment for CMS.

Main Methods:

  • Retrospective case study of five infants and preschool children.
  • Patients presented with respiratory insufficiency as the primary symptom of CMS.
  • Genetic confirmation of CMS and assessment of treatment response.

Main Results:

  • Five children aged 2 weeks to 5 years experienced severe respiratory insufficiency, often exacerbated by viral infections.
  • Patients exhibited progressive muscle weakness, particularly during infections.
  • Treatment with pyridostigmine led to clinical improvement in all five children.

Conclusions:

  • CMS should be considered in pediatric patients with unexplained recurrent respiratory insufficiency or severe respiratory infections.
  • Early diagnosis of CMS is critical to prevent sudden infant death and long-term muscle weakness.
  • Prompt treatment can significantly improve clinical outcomes for children with CMS.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
254
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
189
Respiratory System Abnormal Finding I: Inspection and Percussion01:30

Respiratory System Abnormal Finding I: Inspection and Percussion

Respiratory system abnormalities are a significant concern in healthcare due to their potential to indicate underlying severe conditions like Chronic Obstructive Pulmonary Disease (COPD), asthma, and pneumonia. These abnormalities can often be detected through physical examination methods like inspection and percussion.
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
352
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
60.1K
Physical Assessment of the Respiratory Tract II: Inspection01:27

Physical Assessment of the Respiratory Tract II: Inspection

Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration...
368